Peter Paras Jr.

Array ( [id] => 4288745 [patent_doc_number] => 06235524 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Compositions and methods for screening agents that inhibit MAPK mediated anti-apoptotic signals' [patent_app_type] => 1 [patent_app_number] => 9/431573 [patent_app_country] => US [patent_app_date] => 1999-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 13612 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235524.pdf [firstpage_image] =>[orig_patent_app_number] => 431573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4307982 [patent_doc_number] => 06252132 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Mutant mouse containing a knockout mutation in DNA encoding an endogenous alpha 4 subunit of nicotinic acetylcholine receptor' [patent_app_type] => 1 [patent_app_number] => 9/427581 [patent_app_country] => US [patent_app_date] => 1999-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8006 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/252/06252132.pdf [firstpage_image] =>[orig_patent_app_number] => 427581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355614 [patent_doc_number] => 06218372 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Methods for treating restenosis with p21' [patent_app_type] => 1 [patent_app_number] => 9/426325 [patent_app_country] => US [patent_app_date] => 1999-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6013 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218372.pdf [firstpage_image] =>[orig_patent_app_number] => 426325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1447670 [patent_doc_number] => 06369295 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Uses of transgenic mouse containing a type X collagen mutant' [patent_app_type] => B1 [patent_app_number] => 09/415551 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 11440 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369295.pdf [firstpage_image] =>[orig_patent_app_number] => 09415551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406878 [patent_doc_number] => 06300084 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Anti-mitotic agent screening process' [patent_app_type] => 1 [patent_app_number] => 9/414828 [patent_app_country] => US [patent_app_date] => 1999-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9727 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300084.pdf [firstpage_image] =>[orig_patent_app_number] => 414828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1377262 [patent_doc_number] => 06563017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-13 [patent_title] => 'In vivo electroporation method for early stage embryo of chickens' [patent_app_type] => B2 [patent_app_number] => 09/214565 [patent_app_country] => US [patent_app_date] => 1999-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2226 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/563/06563017.pdf [firstpage_image] =>[orig_patent_app_number] => 09214565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1477801 [patent_doc_number] => 06451594 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Recombinant adenovirus for tissue specific expression in heart' [patent_app_type] => B1 [patent_app_number] => 09/394110 [patent_app_country] => US [patent_app_date] => 1999-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6276 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451594.pdf [firstpage_image] =>[orig_patent_app_number] => 09394110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6211844 [patent_doc_number] => 20020073440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'METHOD FOR SCREENING AND TRANSGENIC MODEL' [patent_app_type] => new [patent_app_number] => 09/367272 [patent_app_country] => US [patent_app_date] => 1999-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4728 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20020073440.pdf [firstpage_image] =>[orig_patent_app_number] => 09367272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1313320 [patent_doc_number] => 06613957 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-02 [patent_title] => 'Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic non-human mammals' [patent_app_type] => B1 [patent_app_number] => 09/388401 [patent_app_country] => US [patent_app_date] => 1999-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 32 [patent_no_of_words] => 19060 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613957.pdf [firstpage_image] =>[orig_patent_app_number] => 09388401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4263179 [patent_doc_number] => 06204432 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'PA28 modified transgenic mice' [patent_app_type] => 1 [patent_app_number] => 9/386746 [patent_app_country] => US [patent_app_date] => 1999-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8233 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204432.pdf [firstpage_image] =>[orig_patent_app_number] => 386746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1567971 [patent_doc_number] => 06376743 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Mammalian transgenesis by intracytoplasmic sperm injection' [patent_app_type] => B1 [patent_app_number] => 09/371648 [patent_app_country] => US [patent_app_date] => 1999-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 13129 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376743.pdf [firstpage_image] =>[orig_patent_app_number] => 09371648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640398 [patent_doc_number] => 06395515 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Directed switch-mediated DNA recombination' [patent_app_type] => B1 [patent_app_number] => 09/369635 [patent_app_country] => US [patent_app_date] => 1999-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 15 [patent_no_of_words] => 12165 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395515.pdf [firstpage_image] =>[orig_patent_app_number] => 09369635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6722540 [patent_doc_number] => 20030056230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'EXPRESSION OF HUMAN ESTROGEN RECEPTORS IN TRANSGENIC MICE' [patent_app_type] => new [patent_app_number] => 09/365614 [patent_app_country] => US [patent_app_date] => 1999-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8241 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20030056230.pdf [firstpage_image] =>[orig_patent_app_number] => 09365614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4269076 [patent_doc_number] => 06322962 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Sterol-regulated Site-1 protease and assays of modulators thereof' [patent_app_type] => 1 [patent_app_number] => 9/360237 [patent_app_country] => US [patent_app_date] => 1999-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 57 [patent_no_of_words] => 52301 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/322/06322962.pdf [firstpage_image] =>[orig_patent_app_number] => 360237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1531149 [patent_doc_number] => 06410029 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => '2-methoxyestradiol-induced apoptosis in cancer cells' [patent_app_type] => B1 [patent_app_number] => 09/351191 [patent_app_country] => US [patent_app_date] => 1999-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 16084 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410029.pdf [firstpage_image] =>[orig_patent_app_number] => 09351191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1148879 [patent_doc_number] => 06770479 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-03 [patent_title] => 'Anthrax vaccine' [patent_app_type] => B1 [patent_app_number] => 09/350729 [patent_app_country] => US [patent_app_date] => 1999-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9790 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770479.pdf [firstpage_image] =>[orig_patent_app_number] => 09350729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1141162 [patent_doc_number] => 06777236 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-17 [patent_title] => 'Process for producing a neuronal host cell in vitro comprising regulatory sequences of the 2-subunit of the neuronal nicotinic acetylcholine receptor' [patent_app_type] => B1 [patent_app_number] => 09/349925 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15219 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/777/06777236.pdf [firstpage_image] =>[orig_patent_app_number] => 09349925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6722539 [patent_doc_number] => 20030056229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'NF-AT POLYPEPTIDES AND POLYNUCLEOTIDES' [patent_app_type] => new [patent_app_number] => 09/349058 [patent_app_country] => US [patent_app_date] => 1999-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21180 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20030056229.pdf [firstpage_image] =>[orig_patent_app_number] => 09349058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521986 [patent_doc_number] => 06414219 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Osteopontin knock-out mouse and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/340484 [patent_app_country] => US [patent_app_date] => 1999-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 36 [patent_no_of_words] => 14058 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/414/06414219.pdf [firstpage_image] =>[orig_patent_app_number] => 09340484 [rel_patent_id] =>[rel_patent_doc_number] =>)